A pair of cases from Academy 2026 show scleral lens refits for severe keratoconus, one addressing focal corneal edema and one fitting around glaucoma tube shunts.
|Videos|April 12, 2022
Nano Magic CEO talks mission for nanotechnology innovation
Author(s)Alex Delaney-Gesing, Senior Editor
Nano Magic's Tom Berman discusses the company's origins and mission in creating nanotech-powered solutions.
Advertisement
Following Vision Expo East, Optometry Times®' Alex Delaney-Gesing catchups up with Tom Berman, president/CEO of
Advertisement
Related to this article
Raman Bhakhri, OD, FAAO, details a session given with Denise Skiadopoulos, OD, FAAO, during the annual AAOpt meeting in Anaheim, California.
Dry eye questionnaires capture only 22.4% of Demodex blepharitis symptoms, and a 22-study review links Demodex infestation to worse meibomian gland function.
Shane Kannarr, OD, overviews results from a phase 4, multicenter, prospective, open-label trial that evaluated the impact of concomitant use of PFHO during contact lens wear.
Real-world PFHO data show OSDI scores falling within 2 weeks, while a 12-month trial finds stable corneal endothelial cell density with cyclosporine 0.1%.
Susan Gromacki, OD, MS, FAAO, FSLS, details one of her AAOpt 2026 sessions, titled "Advances in Contact Lens Care for the New Contact Lens Technologies."
Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Current controversies in macular hole diagnosis, management
2
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
3
FDA approves subcutaneous Enspryng for TED
4
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
5